Clinical Study of Serum Homocysteine and Non-Alcoholic Fatty Liver Disease in Euglycemic Patients

Related articles

19 Jun 2020 : Clinical Research

Association between Cardiorespiratory Fitness, Relative Grip Strength with Non-Alcoholic Fatty Liver Disease

Li Hao, Zhengzhen Wang, [...] Yan Wang, Juan Wang, Zhipeng Zeng - Show fewer authors

DOI: 10.12659/MSM.923015

28 Jun 2020 : Database Analysis

Key genes associated with non-alcoholic fatty liver disease and acute myocardial infarction

Weiran Dai, Yue Sun, [...] Zhiyuan Jiang, Kuan Du, Ning Xia, Guoqiang Zhong - Show fewer authors

DOI: 10.12659/MSM.922492

23 Dec 2019 : Clinical Research

Evaluation of Plateletcrit and Platelet Distribution Width in Patients with Non-Alcoholic Fatty Liver Disease: A Retrospective Chart Review Study

Alihan Oral, Tolga Sahin, [...] Fatih Turker, Erdem Kocak - Show fewer authors

DOI: 10.12659/MSM.920172

14 Feb 2019 : Clinical Research

Myocardial Performance in Elite Athletes: The Role of Homocysteine, Iron, and Lipids

Serkan Duyuler,

DOI: 10.12659/MSM.913561

16 Oct 2018 : Laboratory Research

Efficacy and Clinical Value of Liraglutide for Treatment of Diabetes Mellitus Complicated by Non-Alcoholic Fatty Liver Disease

Zhongyong Zhang, Yueying Qi, [...] Wubao Kong, Qianqian Jin, Xiaoyun Wang, Yanfang Dong, Yuansong Wang, Huajun Li - Show fewer authors

DOI: 10.12659/MSM.911062

19 Oct 2016 : Clinical Research

Altered microRNA-9 Expression Level is Directly Correlated with Pathogenesis of Nonalcoholic Fatty Liver Disease by Targeting Onecut2 and SIRT1

Ran Ao, Ying Wang, [...] Jing Tong, Bai-Fang Wang - Show fewer authors

DOI: 10.12659/MSM.897207

18 Jun 2018 : Clinical Research

Relationship Between Preoperative Low-Density Lipoprotein Cholesterol and Periprocedural Myocardial Injury in Patients Following Elective Percutaneous Coronary Intervention in Southern China

Zhixiong Zhong, Jing Liu, [...] Qifeng Zhang, Wei Zhong, Bin Li, Cunren Li, Zhidong Liu, Min Yang, Pingsen Zhao - Show fewer authors

DOI: 10.12659/MSM.907400

16 May 2017 : Laboratory Research

MiR-149 Compromises the Reactions of Liver Cells to Fatty Acid via its Polymorphism and Increases Non-Alcoholic Fatty Liver Disease (NAFLD) Risk by Targeting Methylene Tetrahydrofolate Reductase (MTHFR)

Xianchao An, Zonglin Yang, [...] Zhengzhuang An - Show fewer authors

DOI: 10.12659/MSM.901377

11 Apr 2017 : Original article

Application of Indocyanine Green (ICG) Detection in Evaluating Early Prognosis in Patients with Fatty Liver Disease After Liver Transplantation

Wenjing Wang, Qiang Zhao, [...] Anbin Hu, Xiaoshun He, Xiaofeng Zhu - Show fewer authors

DOI: 10.12659/AOT.901277

08 Aug 2014 : Original article

Thiazolidinedione Therapy Versus Lifestyle Recommendation in the Treatment of Post-Liver Transplant Graft Steatosis

Fredrik Åberg, Virve Koljonen, [...] Katriina Nikkilä, Sonja Boyd, Johanna Arola, Helena Isoniemi - Show fewer authors

DOI: 10.12659/AOT.890664

19 Mar 2016 : Clinical Research

Sleep Apnea and Fatty Liver Are Coupled Via Energy Metabolism

Ahmet Arısoy, Bunyamin Sertoğullarından, [...] Selami Ekin, Mesut Özgökçe, Mehmet Deniz Bulut, Mehmet Tahir Huyut, Şehmus Ölmez, Mahfuz Turan - Show fewer authors

DOI: 10.12659/MSM.898214

29 Aug 2014 : Original article

Deterioration of Heart Rate Recovery Index in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD)

Olcay Ozveren, Orhan Dogdu, [...] Cihan Sengul, Veysel Cinar, Elif Eroglu, Zekeriya Kucukdurmaz, Muzaffer Degertekin - Show fewer authors

DOI: 10.12659/MSM.890741

16 Dec 2013 : Original article

Nonalcoholic fatty liver disease is associated with low HDL cholesterol and coronary angioplasty in patients with type 2 diabetes

Aleksandra Trojak, Małgorzata Waluś-Miarka, [...] Ewa Woźniakiewicz, Maciej T. Małecki, Barbara Idzior-Waluś - Show fewer authors

DOI: 10.12659/MSM.889649

01 Dec 2012

The BARD score and the NAFLD fibrosis score in the assessment of advanced liver fibrosis in nonalcoholic fatty liver disease

Halina Cichoż-Lach, Krzysztof Celiński, [...] Beata Prozorow-Król, Jarosław Swatek, Maria Słomka, Tomasz Lach - Show fewer authors

DOI: 10.12659/MSM.883601

23 Apr 2012

The prevalence of metabolic risk factors among outpatients with diagnosed nonalcoholic fatty liver disease in Lithuania

Jonas Valantinas, Daiva Asta Apanaviciene, [...] Ligita Maroziene, Audrius Sveikata - Show fewer authors

DOI: 10.12659/MSM.882722

24 Apr 2011

SIRT1 as a potential therapeutic target for treatment of nonalcoholic fatty liver disease

Yasar Colak, Oguzhan Ozturk, [...] Ebubekir Senates, Ilyas Tuncer, Elif Yorulmaz, Gupse Adali, Levent Doganay, Feruze Yilmaz Enc - Show fewer authors

DOI: 10.12659/MSM.881749

01 Dec 2009

Safety and efficacy of combined ezetimibe/simvastatin treatment and simvastatin monotherapy in patients with non-alcoholic fatty liver disease

Tatjana Abel, Janos Feher, [...] Elek Dinya, Mohamed Gamal Eldin, Attila Kovacs - Show fewer authors

25 Sep 2009

Clinical effectiveness of ezetimibe for a non-obese patient with nonalcoholic fatty liver disease

Munechika Enjoji, Masatake Tanaka, [...] Masayuki Miyazaki, Nobito Higuchi, Masaki Kato, Kazuhiro Kotoh, Kazuhisa Matsunaga, Takuya Nishinakagawa, Kazuyuki Machida, Manabu Nakashima, Makoto Nakamuta - Show fewer authors

30 Mar 2009

Elevated serum levels of caspase-cleaved cytokeratin 18 (CK18-Asp396) in patients with nonalcoholic steatohepatitis and chronic hepatitis C

Yusuf Yilmaz, Enver Dolar, [...] Engin Ulukaya, Semra Akgoz, Murat Keskin, Murat Kiyici, Omer Yerci, Arzu Yilmaztepe Oral, Cuma Bulent Gul, Selim Gurel, Selim Giray Nak, Macit Gulten - Show fewer authors

30 Mar 2009

Dipeptidyl peptidase IV inhibitors: therapeutic potential in nonalcoholic fatty liver disease

Yusuf Yilmaz, Ozlen Atug, [...] Oya Yonal, Deniz Duman, Osman Ozdogan, Nese Imeryuz, Cem Kalayci - Show fewer authors

22 Dec 2005

Non-alcoholic fatty liver disease and metabolic syndrome: what we know and what we don't know.

Daad H. Akbar, Abeer H. Kawther